U.S. Interactive Media and Services Stock News

NasdaqGS:MBLY
NasdaqGS:MBLYAuto Components

Mobileye Deepens ADAS Partnerships And Moves Closer To Level 4 Scale

Mobileye Global (NasdaqGS:MBLY) is adding Elektrobit’s Linux platform to its Mobileye Drive system to support Level 4 autonomous driving. The company recently secured a major U.S. OEM win for its advanced driver assistance systems, expanding its ADAS pipeline. Mobileye signed a SuperVision agreement with Mahindra & Mahindra, positioning itself as a Tier 1 supplier and opening new geographic markets. Mobileye Global, known for its driver assistance and autonomous driving technology, is...
NasdaqGS:AVAH
NasdaqGS:AVAHHealthcare

Is Aveanna Healthcare Holdings (AVAH) Still Attractively Priced After Its Recent Multi Year Surge

If you are wondering whether Aveanna Healthcare Holdings is still attractively priced after its recent run, you are not alone. This article focuses on what the current share price could imply about value. The stock last closed at US$7.36, with returns of 0.3% over 7 days, a 10.8% decline over 30 days, an 8.9% decline year to date, and a 72.8% gain over the past year, as well as a very large 3 year return of around 4x. Recent coverage has centred on Aveanna's role in home and pediatric...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

Does The Share Price Of uniQure (QURE) Reflect Its Gene Therapy Prospects?

If you are wondering whether uniQure’s current share price reflects its true worth, this breakdown is designed to help you weigh what you are paying against what you are getting. The stock closed at US$15.63, with returns of a 33.3% decline over 7 days, a 32.1% decline over 30 days, a 33.2% decline year to date, but an 18.9% gain over the past year, which may catch the eye of investors thinking about both risk and recovery potential. Recent news around uniQure has focused on its position in...
NasdaqGM:LMAT
NasdaqGM:LMATMedical Equipment

LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns

LeMaitre Vascular (NasdaqGM:LMAT) reported robust Q4 2025 and full-year 2025 financial results. The company announced a new US$100 million share repurchase program. Management approved a 25% dividend increase for shareholders. LeMaitre Vascular focuses on medical devices for vascular surgeons, so its performance tends to track demand for procedures that treat peripheral vascular disease and related conditions. The combination of strong quarterly and full-year 2025 figures with higher...
NYSE:LEG
NYSE:LEGConsumer Durables

Is Leggett & Platt (LEG) Pricing Reflect Recent Bedding Demand Shifts And DCF Estimate

If you are wondering whether Leggett & Platt is attractively priced or a value trap, starting with a clear view of its recent share performance and valuation checks can help bring that picture into focus. The stock last closed at US$11.68, with returns of 6.3% year to date and 30.1% over the past year, set against longer term 3 year and 5 year returns of 62.0% and 69.7% declines. Recent news around Leggett & Platt has mainly centered on its position in bedding and furniture components, and...
NYSE:PBI
NYSE:PBICommercial Services

Pitney Bowes Funding Moves Reshape Capital Structure And Valuation Story

Pitney Bowes (NYSE:PBI) has launched a $200 million fixed-income offering. The company recently filed a shelf registration to allow more flexible capital raising. These moves follow leadership changes, business transformation efforts, and substantial share buybacks. Pitney Bowes, known for mailing, shipping, and related services, is in the middle of a broader transformation of its operations and leadership. In that context, the combination of a $200 million fixed-income offering and a fresh...
NYSE:NLY
NYSE:NLYMortgage REITs

Annaly Insider Sale Prompts Fresh Look At Valuation And Dividend Risk

A senior executive at Annaly Capital Management (NYSE:NLY) has sold company shares, according to a recent regulatory filing. The transaction involves insider ownership of the mortgage real estate investment trust and comes at a time when there is limited company specific news. Annaly Capital Management focuses on investing in mortgage related assets, a segment that is closely linked to interest rate policy, housing finance conditions, and broader credit markets. When an insider at a company...
NasdaqGS:DFTX
NasdaqGS:DFTXPharmaceuticals

Definium Therapeutics Advances DT120 ODT As Trials And Valuation Gain Focus

Definium Therapeutics' lead asset, DT120 ODT, has received FDA Breakthrough Therapy Designation for generalized anxiety disorder. The company is approaching pivotal phase III readouts across multiple late stage trials and has launched a new phase II study in autism spectrum disorder. Definium is also increasing its commercial readiness by expanding leadership and building operational infrastructure as it moves toward a potential launch phase. For investors watching NasdaqGS:DFTX, this...
NasdaqGS:OLPX
NasdaqGS:OLPXPersonal Products

Should Olaplex’s Faster No.3PLUS Launch Prompt Rethinking of Its Science-Led Brand Strategy (OLPX)?

Earlier this week, OLAPLEX Holdings, Inc. launched No.3PLUS Complete Repair Treatment, a three-minute pre-shampoo product using its patented Bond Building Technology™ and new Damage Defense Cationic Complex, supported by a “Science Never Looked So Good” campaign featuring Chloe Fineman and broad distribution across major retail and online channels. This new treatment extends OLAPLEX’s core bond-repair franchise into a faster, more convenient format, aiming to reinforce its science-led brand...
NYSE:ALK
NYSE:ALKAirlines

How Investors Are Reacting To Alaska Air Group (ALK) Winning a Single Operating Certificate with Hawaiian

In recent weeks, Alaska Air Group secured a single operating certificate for Alaska Airlines and Hawaiian Airlines, while analysts highlighted its stronger-than-expected earnings, improved cost control, and operational discipline. This combination of operational progress and favorable analyst commentary has supported a more constructive view of Alaska Air Group’s earnings potential and business resilience, even as the airline industry remains cyclical and exposed to cost and demand...
NasdaqGS:PDFS
NasdaqGS:PDFSSemiconductor

Assessing PDF Solutions (PDFS) Valuation After Brown Capital’s AI And Semiconductor Supply Chain Bet

PDF Solutions (PDFS) is back on radar after the Brown Capital Management Small Company Fund added the stock in Q4 2025, citing its AI-focused analytics and semiconductor supply chain solutions as key attractions. See our latest analysis for PDF Solutions. At a share price of US$33.78, PDF Solutions has seen a 24.65% 90 day share price return and a 50.00% 1 year total shareholder return, suggesting momentum has picked up as investors respond to its AI and semiconductor supply chain story. If...
NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

Assessing Twist Bioscience (TWST) Valuation After New Invenra Bispecific Antibody Licensing Deal

Twist Bioscience (TWST) is back in focus after announcing a licensing deal with Invenra that brings the B-Body bispecific antibody platform under a co-exclusive arrangement, directly expanding Twist’s antibody discovery service offering. See our latest analysis for Twist Bioscience. The licensing news lands after a strong run, with the latest share price at $46.92, a 30 day share price return of 11.69% and a 90 day share price return of 46.58%. Looking further out, the stock shows a 1 year...
NasdaqCM:PVLA
NasdaqCM:PVLABiotechs

Is Palvella Therapeutics (PVLA) Still Attractive After A 7x One-Year Surge In Price?

If you are wondering whether Palvella Therapeutics at around US$135 is still offering value after a strong run, this article focuses squarely on what the current price might be implying. The stock has moved sharply recently, with a 57.6% return over the last 7 days, 71.5% over 30 days, and 34.6% year to date, while the 1 year return is very large at close to 7x. These moves sit against a backdrop of heightened interest in Palvella Therapeutics, including investor attention around its listing...
NasdaqGS:SPSC
NasdaqGS:SPSCSoftware

SPS Commerce Earnings Beat Meets Insider Selling And Growth Concerns

SPS Commerce (NasdaqGS:SPSC) reported earnings per share that were ahead of expectations, highlighting resilient profitability. Shortly after the results, the CEO sold company shares, drawing attention to insider activity. Craig Hallum downgraded the stock, citing a revenue miss and a softer outlook for 2026. SPS Commerce focuses on cloud based supply chain and retail data services, giving retailers and suppliers tools to manage orders and product information. That positions the company in...
NYSE:MTD
NYSE:MTDLife Sciences

Is Mettler-Toledo (MTD) Pricing Reflect Its Precision Instruments Strength After Recent Pullback

If you are wondering whether Mettler-Toledo International remains a quality business at the current price or if the market has moved ahead of the fundamentals, this article will walk you through what the valuation signals are really saying. The stock last closed at US$1,366.69, with a 7 day return showing a 0.8% decline, a 30 day return showing a 2.5% decline, and a 1 year return of 7.4%. Taken together, this offers a mixed picture of recent sentiment and longer term performance. Recent news...
NYSE:LVS
NYSE:LVSHospitality

Las Vegas Sands Backs UNLV Girls STEM Camp As Valuation Questions Linger

Las Vegas Sands (NYSE:LVS) is supporting the UNLV STEM for Girls Camp, aimed at encouraging girls to pursue science, technology, engineering and math fields. The initiative focuses on expanding access to STEM education for young women in the company’s home region. This support highlights the company’s focus on social responsibility and workforce diversity alongside its core resort and gaming operations. For investors watching Las Vegas Sands at a current share price of $56.72, this new...
NYSE:WCC
NYSE:WCCTrade Distributors

Assessing Wesco International’s Valuation After US$1.5b Senior Notes Offering And Refinancing Steps

WESCO International (WCC) has drawn fresh attention after completing a US$1.5b private offering of unsecured senior notes, using the proceeds to redeem 7.250% notes due 2028 and repay portions of existing credit facilities. See our latest analysis for WESCO International. Despite the fresh financing news and a higher quarterly dividend, the 1-day share price return of 2.14% and 7-day share price return of 2.52% show near term pressure. In contrast, a 90-day share price return of 8.26% and...
NasdaqGS:STRL
NasdaqGS:STRLConstruction

Is It Too Late To Consider Sterling Infrastructure (STRL) After A Huge Five Year Run?

If you are wondering whether Sterling Infrastructure's share price still offers value after a strong run, this article will walk through how that question stacks up against the numbers. The stock recently closed at US$428.13, with returns of 14.6% over the last 30 days, 34.1% year to date, 236.6% over 1 year and a very large gain over 5 years. Recent coverage of Sterling Infrastructure has focused on its role in capital projects and how investor attention has shifted toward companies...
NasdaqGS:MORN
NasdaqGS:MORNCapital Markets

Morningstar Expands Retirement Reach And Data Platform With New Leadership

Morningstar (NasdaqGS:MORN) has launched Foundation Series Collective Investment Trusts in collaboration with Alta Trust Company and several large asset managers. The new CITs focus on providing retirement plans with broader access to institutional investment solutions with an emphasis on simplicity and diversification. Morningstar has also appointed Scott Brown as President of Direct Platform, with a remit to accelerate product development and data platform work. Morningstar, known for its...
NYSE:PACS
NYSE:PACSHealthcare

PACS Group (PACS) Margin Jump To 3.6% Tests Rich 29.9x P/E Narrative

PACS Group (PACS) just wrapped up FY 2025 with Q4 revenue of US$1.4b and basic EPS of US$0.38, supported by trailing twelve month revenue of US$5.3b and EPS of US$1.23 that has been tied to very large year on year earnings growth of 243.5%. Over recent periods, the company has seen quarterly revenue move from US$1.21b in Q4 2024 to US$1.36b in Q4 2025, while quarterly EPS went from US$0.24 to US$0.38. This sets up a results season where strong reported earnings growth, margin improvement to...
NasdaqGS:WGS
NasdaqGS:WGSHealthcare

COO Share Sale Highlights GeneDx Valuation Gap And Recent Stock Pressure

GeneDx Holdings (NasdaqGS:WGS) Chief Operating Officer Bryan Dechairo has sold his entire direct shareholding in an open market transaction. The sale was executed under a Rule 10b5-1 trading plan and leaves Dechairo with no direct equity interest in the company. This insider transaction comes as GeneDx continues to report business growth and operational progress. The move comes at a time when GeneDx shares last closed at $79.71, with the stock showing mixed performance across time frames...
NasdaqGS:WBD
NasdaqGS:WBDEntertainment

Warner Bros. Discovery (WBD) One Off US$2.4b Gain Tests Bullish Profitability Narratives

Warner Bros. Discovery (WBD) has capped FY 2025 with fourth quarter revenue of US$9.5b and a basic EPS loss of US$0.10, setting the tone for a year where profitability on a trailing basis has been supported by a sizeable one off gain. The company has seen quarterly revenue range between US$9.0b and US$9.8b across 2025, with EPS swinging from a loss of US$0.18 in Q1 to a profit of US$0.64 in Q2 before reverting to losses in Q3 and Q4. This leaves investors focusing on how much of the reported...
NasdaqGS:BTSG
NasdaqGS:BTSGHealthcare

BrightSpring Health Services (BTSG) EPS Jump In Q4 2025 Tests Bullish Profitability Narrative

BrightSpring Health Services (BTSG) just closed FY 2025 with fourth quarter revenue of US$3.6b and basic EPS of US$0.24, while net income from continuing operations, excluding extra items, came in at US$49.3m. The company has seen quarterly revenue move from US$3.1b and EPS of US$0.08 in Q4 2024 to US$3.6b and EPS of US$0.24 in Q4 2025, with trailing twelve month EPS at US$0.53 and net income of US$106.3m on US$12.9b in revenue. This puts the latest report firmly in focus for anyone tracking...
NYSE:ESAB
NYSE:ESABMachinery

ESAB Ruffian Launch And Linde Tie Up Put Valuation In Focus

ESAB (NYSE:ESAB) has introduced the Ruffian EMP 270G engine-driven welding generator at CONEXPO-CON/AGG 2026. The unit features advanced inverter technology and more than 100 customer-requested features. The product was developed in collaboration with Linde, with exclusive offerings tied to the trade show launch. ESAB, listed on the NYSE under the ticker ESAB, is a welding and cutting equipment company with a focus on industrial and construction applications. By rolling out the Ruffian EMP...